Winfield Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$239K Buy
21,994
+3,835
+21% +$50.5K 0.09% 137
2021
Q4
$246K Buy
+18,159
New +$242K 0.08% 142

Other funds holding VTRS

Winfield Associates's VTRS Position: Q1 2022 in Review

Winfield Associates increased its Viatris (VTRS) stake by 21% in Q1 2022, buying an estimated $50.5K and bringing the position to 21,994 shares worth $239K. The position accounts for 0.09% of the portfolio, ranked #137.

Winfield Associates first reported a position in VTRS in Q4 2021 and has held it in 2 quarters since. The position peaked at $246K in Q4 2021. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q1 2022.

  • Winfield Associates held 21,994 shares of Viatris worth $239K as of Q1 2022.
  • Winfield Associates bought 3,835 Viatris shares in Q1 2022, an estimated $50.5K.
  • Viatris made up 0.09% of Winfield Associates's portfolio in Q1 2022, its #137 holding.
  • Winfield Associates first reported a position in Viatris in Q4 2021 and has held it in 2 quarters since.
  • Winfield Associates's Viatris position peaked at $246K in Q4 2021.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q1 2022.

Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.